PriceTargets.com logo

China Shineway Pharmaceutical Group - CSWYY Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: C$0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$25.39 As of 04/15/2024 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for CSWYY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New China Shineway Pharmaceutical Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CSWYY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CSWYY

Analyst Price Target is C$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for China Shineway Pharmaceutical Group in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a -100.00% upside from the last price of C$25.39.

This chart shows the closing price for CSWYY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in China Shineway Pharmaceutical Group. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/24/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/22/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/22/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/21/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/19/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/17/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/17/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/16/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/15/2022Jefferies Financial GroupUpgradeHold ➝ Buy$5.70 ➝ $14.00
(Data available from 4/16/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/19/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/19/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/18/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/18/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/17/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/16/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/17/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/16/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.

China Shineway Pharmaceutical Group

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of soft capsules, granules, and injections, as well as TCM formula granules in various therapeutic areas, including respiratory system disease, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, nervous system, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.
Read More

Today's Range

Now: C$25.39
Low: C$25.39
High: C$25.39

50 Day Range

MA: C$21.77
Low: C$17.69
High: C$27.85

52 Week Range

Now: C$25.39
Low: C$22.75
High: C$27.85

Volume

N/A

Average Volume

250 shs

Market Capitalization

N/A

P/E Ratio

1.49

Dividend Yield

2.29%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of China Shineway Pharmaceutical Group?

The following equities research analysts have issued research reports on China Shineway Pharmaceutical Group in the last year:
View the latest analyst ratings for CSWYY.

What is the current price target for China Shineway Pharmaceutical Group?

0 Wall Street analysts have set twelve-month price targets for China Shineway Pharmaceutical Group in the last year. has the lowest price target set, forecasting a price of C$10,000,000.00 for China Shineway Pharmaceutical Group in the next year.
View the latest price targets for CSWYY.

What is the current consensus analyst rating for China Shineway Pharmaceutical Group?

China Shineway Pharmaceutical Group currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for CSWYY.

What other companies compete with China Shineway Pharmaceutical Group?

Other companies that are similar to China Shineway Pharmaceutical Group include 1933 Industries, 4Cable TV International, 4Front Ventures, AB Science and Abacus Health Products. Learn More about companies similar to China Shineway Pharmaceutical Group.

How do I contact China Shineway Pharmaceutical Group's investor relations team?

China Shineway Pharmaceutical Group's physical mailing address is Luan Cheng, Shijiazhuang 051430, China. The company's listed phone number is 86 31 1880 30066. The official website for China Shineway Pharmaceutical Group is www.shineway.com. Learn More about contacing China Shineway Pharmaceutical Group investor relations.